NEOS Investment Management LLC lifted its holdings in Centene Co. (NYSE:CNC - Free Report) by 31.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 31,378 shares of the company's stock after acquiring an additional 7,465 shares during the period. NEOS Investment Management LLC's holdings in Centene were worth $1,901,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Capital Advisors Ltd. LLC boosted its stake in shares of Centene by 75.3% in the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock valued at $25,000 after buying an additional 177 shares during the period. Rialto Wealth Management LLC bought a new stake in shares of Centene during the 4th quarter worth $30,000. OFI Invest Asset Management bought a new position in Centene in the fourth quarter valued at about $33,000. SRS Capital Advisors Inc. raised its stake in Centene by 73.4% during the fourth quarter. SRS Capital Advisors Inc. now owns 631 shares of the company's stock worth $38,000 after acquiring an additional 267 shares in the last quarter. Finally, Riverview Trust Co boosted its stake in shares of Centene by 172.7% in the 4th quarter. Riverview Trust Co now owns 758 shares of the company's stock valued at $46,000 after purchasing an additional 480 shares in the last quarter. 93.63% of the stock is owned by institutional investors.
Centene Stock Performance
CNC stock traded up $0.05 during mid-day trading on Wednesday, hitting $60.50. The company had a trading volume of 606,333 shares, compared to its average volume of 4,589,327. Centene Co. has a 12 month low of $55.03 and a 12 month high of $80.59. The stock's fifty day moving average price is $59.84 and its two-hundred day moving average price is $62.45. The firm has a market cap of $30.01 billion, a PE ratio of 9.69, a price-to-earnings-growth ratio of 0.80 and a beta of 0.40. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11.
Centene (NYSE:CNC - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The company reported $0.80 EPS for the quarter, beating analysts' consensus estimates of $0.49 by $0.31. Centene had a net margin of 2.03% and a return on equity of 13.85%. The company had revenue of $40.81 billion during the quarter, compared to analyst estimates of $38.78 billion. During the same period last year, the business earned $0.45 earnings per share. Centene's revenue was up 3.4% compared to the same quarter last year. On average, analysts forecast that Centene Co. will post 6.86 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of analysts have weighed in on CNC shares. Stephens decreased their target price on shares of Centene from $75.00 to $73.00 and set an "equal weight" rating on the stock in a research note on Friday, December 13th. Jefferies Financial Group lowered Centene from a "hold" rating to an "underperform" rating and lowered their target price for the stock from $68.00 to $52.00 in a research report on Tuesday, December 10th. Oppenheimer decreased their target price on shares of Centene from $95.00 to $85.00 and set an "outperform" rating for the company in a research report on Friday, December 13th. UBS Group upgraded Centene from a "neutral" rating to a "buy" rating and upped their target price for the company from $79.00 to $80.00 in a research report on Friday, December 13th. Finally, Robert W. Baird boosted their target price on shares of Centene from $66.00 to $71.00 in a research report on Tuesday, February 4th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have issued a buy rating to the company's stock. According to MarketBeat.com, Centene has a consensus rating of "Moderate Buy" and a consensus price target of $79.92.
Read Our Latest Stock Analysis on Centene
About Centene
(
Free Report)
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Articles
Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
